INTERNATIONAL AIDS VACCINE INITIATIVE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 22233
 
  
 
C07K PEPTIDES 17119
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 14153
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5201
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0057,570 BROADLY NEUTRALIZING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120-SPECIFIC MONOCLONAL ANTIBODYSep 12, 17Mar 01, 18[A61K, C07K]
2017/0258,890 GENETICALLY STABLE REPLICATION COMPETENT SENDAI VIRUS VECTOR(S) CONTAINING AND EXPRESSING OPTIMIZED HIV GENESApr 27, 17Sep 14, 17[A61K, C12N, C07K]
2016/0033,532 MAMMALIAN PROTEIN CO-RECOGNITION BY BROADLY NEUTRALIZING ANTIBODIES AS MODIFIED IMMUNOGENS FOR RE-ELICITATIONJul 30, 15Feb 04, 16[A61K, G01N]
2015/0218,257 MONOCLONAL ANTIBODIES DIRECTED AGAINST TRIMERIC FORMS OF THE HIV-1 ENVELOPE GLYCOPROTEIN WITH BROAD AND POTENT NEUTRALIZING ACTIVITYApr 21, 15Aug 06, 15[C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920111 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityApr 21, 15Mar 20, 18[A61K, C07K]
9802986 Recombinant viral vectorsDec 17, 15Oct 31, 17[A61K, C12N, G01N, C07K]
9796774 HIV-1 broadly neutralizing antibodiesApr 19, 16Oct 24, 17[A61K, G01N, C07K]
9738688 HIV-1 envelope glycoproteinNov 05, 13Aug 22, 17[A61K, C07K]
9707290 Immunogens of HIV-1 broadly neutralizing antibodies, methods of generation and uses thereofMar 10, 15Jul 18, 17[A61K, C12Q, C12N, C07K]
9610346 Recombinant viral vectorsMar 10, 13Apr 04, 17[A61K]
9562078 Methods for identifying broadly neutralizing antibodies utilizing recombinant HIV-1 envelope glycoproteins comprising stabilizing mutationsJun 27, 13Feb 07, 17[A61K, C12N, G01N, C07K]
9464131 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyFeb 28, 13Oct 11, 16[A61K, C07K]
9402894 Viral particles derived from an enveloped virusOct 26, 12Aug 02, 16[A61K]
9382311 HIV-1 broadly neutralizing antibodiesMar 10, 13Jul 05, 16[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0065,381 METHODS OF IDENTIFYING NOVEL HIV-1 IMMUNOGENSAbandonedSep 05, 14Mar 05, 15[G01N]
2014/0322,269 ENGINEERED OUTER DOMAIN (EOD) OF HIV GP120 AND MUTANTS THEREOFAbandonedApr 11, 14Oct 30, 14[A61K, C07K]
2013/0189,754 IMMUNOSELECTION OF RECOMBINANT VESICULAR STOMATITIS VIRUS EXPRESSING HIV-1 PROTEINS BY BROADLY NEUTRALIZING ANTIBODIESAbandonedSep 12, 12Jul 25, 13[A61K]
2013/0095,556 NOVEL VESICULAR STOMATITIS VIRUS AND VIRUS RESCUE SYSTEMAbandonedSep 20, 12Apr 18, 13[C12N]
2012/0258,124 ANTIGEN-ANTIBODY COMPLEXES AS HIV-1 VACCINESAbandonedJan 31, 12Oct 11, 12[A61K, A61P]
8105600 Method of inducing high-titer neutralizing antibody responses in a host by administering immune complexes comprising anti-HIV-1 Env antibodies and the HIV-1 EnvExpiredOct 30, 08Jan 31, 12[A61K]
2011/0217,338 HIV-1 Envelope Based FragmentsAbandonedMar 02, 11Sep 08, 11[A61K, G01N, A61P, C07K]
7993651 Chimeric human immunodeficiency virus (HIV) immunogens comprising GAG P24-P17 fused to multiple cytotoxic T lymphocyte (CTL) epitopesExpiredDec 22, 00Aug 09, 11[A61K]
2011/0123,556 IMMUNOGEN PRIORITIZATION FOR VACCINE DESIGNAbandonedNov 22, 10May 26, 11[A61K, B82Y, G01N, A61P]
2010/0215,691 RECOMBINANT VIRAL VECTORSAbandonedFeb 19, 10Aug 26, 10[A61K, C12N, A61P]
2008/0274,992 RECOMBINANT MODIFIED ANKARA VIRAL HIV-1 VACCINESAbandonedMar 26, 08Nov 06, 08[A61K, A61P]
2008/0102,073 Antigen-Antibody Complexes as HIV-1 VaccinesAbandonedOct 30, 07May 01, 08[A61K]
2008/0038,297 GENETIC ADJUVANTS FOR VIRAL VACCINESAbandonedApr 26, 07Feb 14, 08[A61K, A61P]
6531313 Invasive bacterial vectors for expressing alphavirus repliconsExpiredOct 26, 00Mar 11, 03[C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.